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14-3-3 proteins regulate cellular responses to stimuli by docking onto pairs of
phosphorylated residues on target proteins. The present study shows that the
human 14-3-3-binding phosphoproteome is highly enriched in 2R-ohnologues,
which are proteins in families of two to four members that were generated by
two rounds of whole genome duplication at the origin of the vertebrates. We
identify 2R-ohnologue families whose members share a ‘lynchpin’, defined as
a 14-3-3-binding phosphosite that is conserved across members of a given
family, and aligns with a Ser/Thr residue in pro-orthologues from the invert-
ebrate chordates. For example, the human receptor expression enhancing
protein (REEP) 1–4 family has the commonest type of lynchpin motif in current
datasets, with a phosphorylatable serine in the –2 position relative to the 14-3-
3-binding phosphosite. In contrast, the second 14-3-3-binding sites of REEPs
1–4 differ and are phosphorylated by different kinases, and hence the
REEPs display different affinities for 14-3-3 dimers. We suggest a conceptual
model for intracellular regulation involving protein families whose evolution
into signal multiplexing systems was facilitated by 14-3-3 dimer binding to
lynchpins, which gave freedom for other regulatory sites to evolve. While
increased signalling complexity was needed for vertebrate life, these systems
also generate vulnerability to genetic disorders.2. Introduction
Around 500 Ma, the vertebrates emerged from a massive evolutionary uphea-
val that involved two rounds of whole genome duplication (2R-WGD), with
additional subsequent WGDs in certain lineages of bony fish and amphibians.
Compelling evidence for these events emerged only recently, when the genomic
signatures of the 2R-WGD were traced from invertebrates through to humans
and other vertebrates [1,2]. A key new data source is the genome sequence of
amphioxus (lancelet, Branchiostoma), the least-derived living invertebrate rela-
tive of the vertebrates within the phylum Chordata. Protein-coding gene
duplicates that stem from the 2R-WGD are termed 2R-ohnologues. Generally,
amphioxus has one ‘ancestral’ protein for each human 2R-ohnologue family.
However, losses mean that only 15 to 30 per cent of genes in modern-day
humans still belong to 2R-ohnologue families containing two to four members
[1,2]. This raises several important questions: why did only certain gene
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And what is their impact on human health and diseases?
Lists of human 2R-ohnologues were compiled recently
and mapped onto datasets of genes that underpin biochemi-
cal events and diseases [2–4]. The human 2R-ohnologues
were found to be less likely than non-ohnologues to
have undergone subsequent small-scale duplications. This
finding is consistent with the concept that present-day
2R-ohnologues have been maintained in dosage-balanced
sets. Each of these sets is thought to contribute to a
common process or structure that would be upset by chan-
ging the level of one or a few components [2]. Strikingly,
many 2R-ohnologue families include Mendelian disease
genes, which is also in line with the gene–dosage balance
hypothesis [2,4,5]. Human 2R-ohnologues are also enriched
in components of growth factor and developmental signal-
ling pathways, and preferentially expressed in the nervous
system and in vertebrate-specific organs [3]. The overall
impression is that balanced sets of 2R-ohnologue families
supported the evolution of vertebrate specialities, while also
introducing vulnerability to genetic diseases.
In addition to the hypothesized retention of 2R-ohnologues
owing to dosage-balance, it is thought that duplicate genes are
often retained when they diverge to gain new functions (neo-
functionalization) or partition subfunctions of their ancestral
gene between the duplicates [6,7]. However, domain architec-
tures are often conserved across 2R-ohnologue families, so it
seems likely that functional genetic divergence may occur in
the linker sequences between the domains, which tend to
evolve faster than the functional domains and are enriched in
regulatory phosphorylation sites [8].
Phosphorylated motifs are conserved to different degrees
within protein families and across species. Some regulations
require a precisely positioned phosphorylation, whereas in
other cases the density of charge matters more than position
[8–13]. Many phosphorylated residues dock onto regulatory
proteins whose specificities may further constrain the evol-
ution of the phosphoprotein.
The eukaryotic 14-3-3s comprise one such family of phos-
phoprotein-binding proteins. Their name refers to their
discovery as proteins in fraction 14-3-3 in a sequential
DEAE–cellulose and starch–gel separation of brain extract.
14-3-3s are dimers that dock onto specific pairs of phosphory-
lated serine and threonine residues on many proteins. These
targets include human proteins that are linked to metabolic
and neurological disorders, and to cancer [14]. By docking
onto two phosphorylated residues that may be phosphory-
lated by different kinases, a 14-3-3 dimer can act as a logic
gate that integrates two inputs. The bound 14-3-3 dimer
may mask a functional domain in the target protein, or
induce a conformational change [14–17]. Thus, a 14-3-3
dimer is a protein device that integrates two kinase signalling
inputs and exerts a mechanical action on the target.
14-3-3-binding motifs generally have at least one basic
residue in the23 to25 positions relative to the phosphorylated
serine or threonine, and never a þ1 proline [14,17]. Such
sequences are phosphorylated by AGC (protein kinase
A/protein kinase G/protein kinase C family) and CAMK
(Ca2þ/calmodulin-dependent protein kinase) protein kinases,
including PKA (protein kinase A), Akt/PKB (protein kinase
B), SGK (serum and glutocorticoid-regulated kinase), p90RSK
(90 kDa ribosomal protein S6 kinase), PKCs (protein kinase C
family members) and AMPK (AMP-activated protein kinase)[18]. Therefore, 14-3-3s mediate cellular responses to insulin,
growth factors and other stimuli that activate these kinases
[14,19].
Recent studies of two sister Rab-GTPase activating pro-
teins (AS160/TBC1D4 and TBC1D1) that regulate glucose
uptake into muscles inspired speculation that 14-3-3 dimers
could provide an evolutionary mechanism for the regulatory
divergence of their targets [14]. AS160 and TBC1D1 each
contain two 14-3-3-binding sites: one site is similar in both
proteins, but the second site differs between them. The
14-3-3-binding site common to each protein is an insulin-
regulated Akt/PKB-phosphorylated site. The second site on
AS160 is phosphorylated by Akt/PKB and p90RSK, whereas
on TBC1D1 it is phosphorylated by kinases including AMPK,
which is activated in energy-depleted cells [20–22]. It is there-
fore inferred that AS160 and TBC1D1 have complementary
roles in regulating glucose homoeostasis in response to
insulin and energy stress, respectively [23].
Accordingly, we proposed the lynchpin hypothesis. Sup-
pose that an ancestral 14-3-3-binding protein were duplicated.
Then, if one 14-3-3-binding site remained unchanged, it could
provide a ‘lynchpin’ whose binding to a 14-3-3 dimer might
provide sufficient intracellular control to permit the second
14-3-3-binding site to evolve into a consensus for phosphoryl-
ation by a different protein kinase. The result would be two
proteins with the same function, but regulated by different
signalling inputs [14].
Here, we wished to progress from an anecdotal to a more
systematic analysis. Therefore, we classified human proteins
for which 14-3-3-binding sites have been reported, and dis-
covered that the majority are also 2R-ohnologues. Sequence
alignments indicated interesting patterns of conservation
and divergence of 14-3-3-binding sites across 2R-ohnologue
families. We investigated these in the REEP protein family,
which includes the Hereditary Spastic Paraplegia 31 protein
REEP1. Our findings have implications for understanding
the evolution of vertebrates, and also for certain neuro-
developmental disorders, metabolic diseases and cancer.
Further, we suggest a conceptual model for considering intra-
cellular regulation in terms of multiple-input multiple-output
(MIMO) array systems.3. Results
3.1. Most well-defined human 14-3-3-binding proteins
are 2R-ohnologues
Two published lists of human 2R-ohnologues overlap by 6374
genes [2,3], with a further 920 genes uniquely assigned as
2R-ohnologues in one study [2] and 3096 in the other [3]
(figure 1a). Much of the difference is due to a larger number
of families of five or more genes being counted as 2R-
ohnologues in the latter study. By definition, a 2R-ohnologue
family is not expected to contain more than four protein-
coding genes, unless there have been further duplications
after the 2R-WGD. Thus, when there are insufficient data to
sort larger families of paralogues into their respective
2R-ohnologue subsets, these have been left unresolved as
families of five or more as a temporary measure (figure 1a).
Genes from these two studies were matched to the corre-
sponding human proteins with UniProt identifiers. In this
way, 7104 [2] and 9367 [3] out of the 20 244 non-redundant
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Figure 1. Enrichment of 2R-ohnologues among well-defined 14-3-3-binding
phosphoproteins. (a) 2R-ohnologues in the human proteome. Two published
2R-ohnologue gene datasets (PNAS, green) [2] and (BMC, blue) [3] were
transcribed onto the human proteome (20 244 proteins in UniProt release
08-2011), and plotted according to 2R-ohnologue protein family sizes
assigned in [2] and [3] (see the electronic supplementary material, table S2).
The Venn diagram depicts the overlap of 2R-ohnologues assigned by the two
studies. (b) Gold and silver 14-3-3-binding protein 2R-ohnologue families. Up
to August 2011, 172 gold standard (GD) proteins with defined 14-3-3-binding
phosphosites had been identified, while a further 35 are silver standards (SL)
whose direct phosphorylation-dependent binding to 14-3-3 has been
demonstrated but the relevant sites not pinpointed [14,24] (electronic
supplementary material, table S1). These 207 proteins were assigned into
2R-ohnologue families of 2, 3, 4 and 5 or more proteins according to the
assignments in (a) (green and blue, as before). In red are the 2R-ohnologue
families assigned in this study by abbreviated forms of the procedures given
for the REEP proteins in figures 4 and 5. The hypergeometric probabilities of
the observed distributions occurring by chance are indicated. For the
manually curated data (this study), the two hypergeometric probabilities
represent comparisons with the whole proteome datasets from [2] and
[3], respectively.
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of two or more proteins (figure 1a).
There are 172 ‘gold standard’ human proteins with
well-defined 14-3-3-binding sites, and a further 35 ‘silver stan-
dards’ for which direct phosphorylation-dependent binding to
14-3-3s has been demonstrated, but relevant phosphosites not
yet pinpointed [14,24] (electronic supplementary material,
table S1). We compared this list of 207 14-3-3-binding proteins
with the published 2R-ohnologue lists [2,3], and also with a
2R-ohnologue list that we compiled by performing phyloge-
netic and gene synteny analyses for every 14-3-3-binding
protein (examples of such analyses are given later). Strikingly,
approximately 84 per cent (174/207) of gold and silver14-3-3-binding proteins are 2R-ohnologues, belonging to 139
protein families with a total of 525 family members
(figures 1b and 2; electronic supplementary material,
table S2). Therefore, compared with human proteins in
general (figure 1a), the 14-3-3-binding phosphoproteome is
highly enriched in membership of 2R-ohnologue families
(figures 1b and 2).
3.2. Using 2R-ohnologue datasets to help create a
priority list for validation of high-throughput
14-3-3-capture experiments
In addition to gold and silver 14-3-3-binding proteins,
1772 proteins had been isolated from mammalian cell and
tissue lysates by 14-3-3-affinity capture in 16 high-throughput
(HTP) proteomics experiments up to August 2010 (figure 3a)
[24]. It is therefore imperative to sort these proteins into a
manageable priority list for the future determination of
which are true 14-3-3-interactors; which bind indirectly to
14-3-3s as components of multi-subunit complexes; and
which proteins had been isolated because they bind non-
specifically to affinity matrices. The overlap between these
HTP experiments and 2R-ohnologues is approximately 825
proteins, in 564 families with a total of 2023 members
(figure 3b). Given the striking enrichment of 2R-ohnologues
among the well-defined 14-3-3-binding proteins (figures 1b
and 2), we suggest that the 2R-ohnologues from the HTP
screens should receive priority attention.
As an additional way to filter potential non-specific hits
from the HTP 14-3-3 proteomics datasets, we prepared an
‘exclusion list’ of potential contaminants using data provided
by colleagues, who had isolated proteins from human cell
lysates using ‘control’ beads or ligands unrelated to 14-3-3s.
Interestingly, there is a relatively clean separation between
the gold and silver 14-3-3-binding proteins, and these con-
taminants (see figure 3a; electronic supplementary material,
table S3). Applying the 2R-ohnologues as an ‘inclusion list’
and the common contaminants as ‘exclusion list’ to the pro-
teins identified in HTP 14-3-3 proteomics screens resulted
in a list of 750 proteins that represent 538 families with
a total of 1929 members (see electronic supplementary
material, table S3).
In summary, while the numbers are impossible to predict
precisely, there are strong indications that the total overlap
between 2R-ohnologues and 14-3-3-binding phosphoproteins
may be substantial, and it may be helpful to focus on this
subset when selecting candidates for biochemical experiments.
3.3. Disease associations of 2R-ohnologue families that
include 14-3-3-binding proteins
An association between 2R-ohnologues and human genetic
disease has already been pointed out [2]. Here, we examined
the disease associations of 2R-ohnologue families that contain
the gold and silver 14-3-3-binding proteins, and found that a
striking 91 per cent of these families (127 out of 139) and 64
per cent of the 2R-ohnologue proteins (350/525) are associ-
ated with a disease; developmental, cancer and psychiatric
were the most represented disease categories (see electronic
supplementary material, table S2 and figure S1). Interest-
ingly, for 76 families, different members of the same family
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Figure 2. 14-3-3-binding proteins in their 2R-ohnologue families. Each 2R-ohnologue family is in a box, with the gold and silver standard 14-3-3-binding proteins
in bold, and family members that have not been shown to bind to 14-3-3 in regular text. Previous studies also concluded that the following comprise 2R-ohnologue
sets: mdm2 and mdm4 [25]; beta and gamma catenin [26]; MITF, TFE3, TFEB and TFEC [27]; YAP1 and WWTR1 (TAZ) [28]; the ANNAT family [29]. Pseudogenes
were not included, such as the human IRS3 pseudogene, which otherwise conforms to the gene synteny pattern of a 2R-ohnologue. Also, MFF, listed here as a non-
ohnologue, is related to a human pseudogene (LOC392452). There were cases where post-2R-WGD gene rearrangements were evident, such as TESK1 and TESK2,
though, in line with previous analyses [2], these were few.
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Figure 3. Visualization of the mapping of 2R-ohnologue families onto the 14-3-3 interactome. (a) A graph created using VisANT (visant.bu.edu) [30], from the data
collated in electronic supplementary material, table S2, shows the overlapping sets of proteins that were isolated from mammalian cells in 16 HTP 14-3-3-affinity capture
experiments published up to August 2010 [24]. Each study was assigned a node in blue and lines connect these articles to the identified proteins, depicted with a default
of green circle nodes. Then, well-defined gold and silver standard 14-3-3-binding proteins (see the electronic supplementary material, table S1) were changed from green
to red. Proteins from the ‘common contaminants’ list (electronic supplementary material, table S3) were changed to black. Thereafter, proteins were assigned to
2R-ohnologue families, which were depicted as rectangles whose internal structure is described in panel (c). The interactive version of this graph is available under 14-3-3
partners at http://www.ppu.mrc.ac.uk/research. (b) (i) The overlap between the HTP 14-3-3 affinity capture experiments (a) and 2R-ohnologues is 825 proteins according to
the 2R-ohnologue assignment of [2]. (ii) Classification of these 825 2R-ohnologue proteins into families of 2, 3, 4 and 5 or more proteins. (c) The box in (a) was expanded
to visualize the REEP protein family members, which reveals that REEP3 had been identified in two HTP 14-3-3-affinity capture experiments, while REEP4 had been
reported in one HTP experiment and had also achieved gold standard status by identification of a 14-3-3-binding phosphosite. The interactive version of the VisANT graph
(a) reveals similar details for any protein or protein family by clicking on nodes on the graph, or entering the required UniProt protein name into a search box.
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Figure 4. Gene synteny analysis of the vertebrate REEP 1–4 proteins. (a) Gene synteny clusters ( paralogons) within the human genome were identified using only
the human REEP1, REEP2, REEP3 and REEP4 genes as queries of the Synteny Database (http://teleost.cs.uoregon.edu/synteny_db/) [36] (left), with the search
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KDM3A, JMJD1C, KDM3B.
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supplementary material, table S2 and figure S1).3.4. Evolutionary history of the human REEP proteins
and their ‘lynchpin’ 14-3-3-binding site
To identify potential ‘lynchpins’, we determined how many
published 14-3-3-binding phosphosites are conserved across
the respective 2R-ohnologue family and align with serine or
threonine residues in the corresponding pro-orthologues
of the invertebrate chordates, namely Branchiostoma
(amphioxus) and Ciona (tunicates). Not all sites could be
assigned one way or another because many of the invert-
ebrate protein sequences in the databases are incomplete.
However, 103 experimentally defined sites in 76 protein
families are conserved across the human protein family and
find a matching serine or threonine in the sequences from
the chordate invertebrates (see electronic supplementary
material, table S2 and figure S2). One such conservedpotential ‘lynchpin’ is in the receptor expression enhancing
protein (REEP) family (figure 3c, and later).
The six REEP proteins include REEP1, which is mutated in
hereditary spastic paraplegia 31 (one of a group of disorders
characterized by progressive weakness and stiffness of the
legs), and REEP4, loss of which causes paralysis in Xenopus
[31,32]. REEP proteins are tethered to the cytoplasmic face of
the endoplasmic reticulum (ER) and contiguous membranes,
and are implicated in ER morphology (as are the other heredi-
tary spastic paraplegia proteins atlastin and spastin),
mitochondrial function, and translocation of olfactory, taste
and other receptors to the cell surface [33,34].
Phylogeny, gene syntenyand sequence alignments indicate
that two REEP genes in invertebrate chordates—185 339 and
57 028 (proteins C3ZZ30 and C3Z345) of Branchiostoma
floridae—gave rise to two separate 2R-ohnologue families in
vertebrates: REEPs 1–4 and REEPs 5–6, respectively. The
latter, including the amphioxus pro-orthologue, lack the 14-3-
3-binding region and are not considered further. Human
REEPs 1–4 display the genetic signatures expected for a
family derived from 2R-WGD and not from small-scale
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chromosomes (REEP1 is at 2p11.2, REEP2 lies within the mye-
lodysplastic syndrome (MDS) 5q31.2microdeletion [35],REEP3
is at 10q21.3 and REEP4 at 8p21.3), and the genes for human
REEPs 1–4 are in chromosomal segments that share conserved
neighbouring genes: that is, they reside in ‘paralogons’ (figure
4). The phylogenetic tree shows single invertebrate REEP
genes clustering as a sister group to the clade of all four ver-
tebrate paralogy groups. The tree topology is consistent with
that expected if the first round of whole genome duplication
(1R-WGD) gave rise to two genes, and then in the 2R-WGD
one of these genes gave rise to REEP1 and REEP2, whereas
the other duplicated to make REEP3 and REEP4 (see figure 5a;
electronic supplementary material, figure S3). Interestingly,
REEP4 is missing from the bony fish.
Ser152 of REEP4 is a phosphorylated residue whose
mutation to Ala prevents its binding to 14-3-3s in cell lysates,
and which lies within a motif resembling a typical 14-3-3-
binding site (RLRSF(s152)MQ, where the lower case ‘s’ is
phosphorylated) [24]. All four human REEP proteins have a
Ser that corresponds to Ser152, with minor variations at 25
(Lys in REEP2) and þ2 (His in REEP3), and this residue is
therefore a potential lynchpin (figure 5b). Variations on this
14-3-3-binding motif are found in the REEP orthologues of
species within the Bilateria (figure 5b), and although phos-
phorylation cannot be inferred from sequence alone, this is
consistent with the possibility that this 14-3-3-binding motif
was in place in the chordates prior to the 2R-WGD at the
origin of the vertebrates (figure 5b). All four vertebrate
REEP proteins also have a –2 serine (Ser150 in REEP4)
that is recorded as a phosphosite (www.phosphosite.org;
figure 5b). Interestingly, the gold standard human 14-3-3-
binding sites are enriched in phosphorylatable –2 serines,
whereas other random sets of phosphorylated sites are not
(see electronic supplementary material, figures S2 and S4).3.5. Human REEP1, 2, 3 and 4 are differentially
regulated by phosphorylation and 14-3-3s
To understand how sequence relates to function, we exam-
ined the regulation of REEPs 1-4 biochemically. We raised a
phospho-specific antibody, which revealed that phosphoryl-
ation of Ser152 of REEP4 was unaffected by various
extracellular stimuli, including phorbol ester, and yet phorbol
ester slightly increased the binding of 14-3-3s to REEP4
(figure 6a). Moreover, Ser152Ala-REEP4 mutant protein
bound to 14-3-3 only in lysates of phorbol ester-stimulated
cells, and this was blocked by the broad spectrum protein
kinase C (PKC) inhibitor Go¨6983, but not the PKCa and
PKCb-selective inhibitor Go¨6976, nor p90RSK inhibitor
BI-D1870 (figure 6a). These data suggested the existence of
a second 14-3-3-binding site on REEP4, which was phos-
phorylated by a PKC, or PKC-activated protein kinase other
than p90RSK, in response to phorbol ester. Mutation of
Ser224 decreased overall 14-3-3 binding to REEP4 and pre-
vented the phorbol ester stimulation of 14-3-3 binding (see
figures 6b and 7; electronic supplementary material,
figure S5). These data indicate that a 14-3-3 dimer binds to
both phosphoSer152 and phorbol ester-regulated phospho-
Ser224 on REEP4 (figure 7a). Similar to REEP4, REEP3
also binds to 14-3-3 via phosphoSer152 and Ser225
(see figures 6c and 7b; electronic supplementary material,figure S5). Consistent with the cellular data, in vitro
phosphorylation by PKCz enabled REEP3 and REEP4, but
not REEP1 and REEP2, to bind to 14-3-3 (figure 6d(i)).
Ser224 is the PKCz-phosphorylated site on REEP4 since
its mutation to alanine prevented PKCz-mediated 14-3-3
binding (figure 6d(ii)).
In contrast, the weak binding of 14-3-3 to REEP1 was not
regulated by PMA (see figure 6c; electronic supplementary
material, figure S5), but was enhanced by treating cells with
the protein phosphatase inhibitor calyculin A (not shown).
Analysis of point mutants indicated that phosphoSer192 of
REEP1 is a second 14-3-3-binding site, which is phosphory-
lated by an unknown kinase (see electronic supplementary
material, figure S5; figure 7b). REEP2 did not bind signifi-
cantly to 14-3-3, though it is phosphorylated on a serine
residue analogous to REEP4-Ser152 (see figure 6c; electronic
supplementary material, figure S5), and no second site on
REEP2 has yet been identified.
3.6. Human REEP4 binds to the RAB3GAP1–RAB3GAP2
heterodimer whose mutations underlie Warburg
Micro and Martsolf syndromes
In addition to 14-3-3s, mass fingerprinting of Coomassie-
stained gels and Western blotting of REEP-GFP proteins
isolated from cell lysates showed that REEP4 binds to
RAB3GAP1 and RAB3GAP2 (figure 6b,c), which together
form a heterodimeric GTPase-activating protein for the small
GTPase Rab3. Mutations in RAB3GAP1 and RAB3GAP2
cause the neurodevelopmental Warburg Micro (OMIM 60018)
and Martsolf (OMIM 21270) syndromes, respectively [38–40].
Intriguingly, RAB3GAP1 and RAB3GAP2 do not bind to
Ser152Ala-REEP4 (figure 6b,e). However, despite sharing
Ser152 as a common binding determinant, the interactions
of 14-3-3s and RAB3GAP1–RAB3GAP2 heterodimer with
REEP4 differ. In contrast to 14-3-3s, RAB3GAP1 and
RAB3GAP2 bind to unphosphorylated REEP4 (see electronic
supplementary material, figure S5) and binding of
RAB3GAP1 and RAB3GAP2 to REEP4 was not decreased
when acidic residues took the place of Ser152 (figure 6b).
Also, Ser224Ala-substituted REEP4 had enhanced binding
to RAB3GAP1–RAB3GAP2, but almost no 14-3-3 interaction
(figure 6b,e). Thus, 14-3-3s and the RAB3GAP1–RAB3GAP2
heterodimer must be in distinct REEP4-containing complexes.
Further analyses with a series of chimeric proteins that
contain different combinations of parts of REEP3 and
REEP4 indicated that the mid-region of REEP4 binds to
RAB3GAP1 and RAB3GAP2, whereas the C-terminal third
of REEP4 appears to be slightly inhibitory for RAB3GAP1–
RAB3GAP2 binding (see electronic supplementary material,
figure S5).4. Discussion
4.1. The lynchpin hypothesis and evolution of signal
multiplexing by 2R-ohnologue families
Our data suggest a new conceptual model for intracellular
regulation in terms of protein families that evolved into
signal multiplexing systems in the vertebrates. We propose
that the binding of 14-3-3 dimers to one phosphorylated
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Figure 5. Phylogenetic tree of the vertebrate REEP 1–4 proteins and evolution of the lynchpin 14-3-3-binding phosphorylation site. (a) The phylogenetic tree of the
vertebrate REEP 1–4 proteins shows the topology expected from the 2R-WGD events. Sequences were aligned using MAFFT within JALVIEW (http://www.jalview.org/).
The neighbour-joining tree was constructed in PHYLIP (http://evolution.genetics.washington.edu/phylip.html), using the JTT model and 1000 bootstrap replicates.
Numbers above the branches show the bootstrap support for that branch. Only values over 700 (i.e. 70%) are shown, except for the value uniting vertebrate REEP 3
and 4 groups, which falls just below this value (at 621). The tree is rooted with the non-metazoan choanoflagellate sequence from Monosiga brevicolis as the
outgroup. The vertebrate REEP 1–4 proteins cluster with the four human proteins into four paralogy groups represented by triangles, with the expanded version
given in electronic supplementary material, figure S3. (b) Sequence alignments with the ‘lynchpin’ 14-3-3-binding motif on human REEP 1–4 (Ser152 of REEP4).
The lynchpin region of the human REEP 1–4 was aligned with corresponding sequences from selected metazoan species of the Bilateria, which comprise
Deuterostomia (bottom nine sequences) and Protostomes (Ecdysozoa—three sequences shown; and Lophotrochozoa—four shown); and non-Bilaterian basal
metazoans (top four sequences), according to the super-phylum classification outlined by Telford & Copley [37]. Serine and threonine residues that align with Ser152
of human REEP4 are in red, and basic residues that align with those in the 14-3-3-binding motif are in dark blue.
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Figure 6. Differential regulation of vertebrate REEP 1–4 proteins. (a) Effect of different stimuli/inhibitor combinations on the cellular regulation of REEP4-GFP.
HEK293 cells were transfected to express REEP4-GFP (wild-type) and REEP4-S152A-GFP, serum-starved for 8 h, then stimulated with or without inhibitors, as
indicated. REEP4–GFP was isolated from cell lysates (anti-GFP IPs) and blotted with the antibodies indicated. Also, the ability of the GFP–REEP4 proteins to bind
directly to 14-3-3 was tested with a 14-3-3 Far-Western assay. The blots of cell lysates (30 mg) show the phosphorylation of Ser152 of REEP4, and efficacy of EGF
and PMA in stimulating Erk phosphorylation, and forskolin in stimulating VASP phosphorylation. (b) Effect of mutations on interactions of REEP4 with other proteins.
Wild-type REEP4-GFP or the single site mutant proteins indicated were isolated from HEK293 cell lysates and blotted with the antibodies shown, and probed in a
Far-Western assay for direct binding to 14-3-3s. (As here, it is typical that Asp and Glu do not mimic phosphorylated residues with respect to 14-3-3 binding.)
(c) Interaction of REEP proteins with 14-3-3, RAB3GAP1 and RAB3GAP2. The indicated REEP-GFP proteins were isolated from lysates of transfected cells (anti-GFP IP).
Copurification of endogenous RAB3GAP1, RAB3GAP2 and 14-3-3 was detected by immunoblotting, and the ability of REEP proteins to bind directly to 14-3-3 was
also tested by Far-Western assay. (d ) PKCz phosphorylation and 14-3-3 binding of REEP1, 2, 3 and 4 in vitro. (i) GST-tagged REEP proteins (Y65-end, lacking the N-
terminal membrane-binding regions) were expressed and purified from Escherichia coli, and phosphorylated in vitro with PKCz. Protein (500 ng) was analysed by 14-
3-3 Far-Western assay to detect direct binding to 14-3-3s. (ii) Wild-type REEP4 and putative 14-3-3-binding site mutants were assessed for PKCz-mediated 14-3-3
binding. (e) Reciprocal interaction of RAB3GAP1 with REEP4. Endogenous RAB3GAP1 was immunoprecipitated from HEK293 cells transfected with plasmids to express
wild-type or mutant forms of REEP4-GFP. The immunoprecipitates were blotted with the antibodies shown. A control immunoprecipitation was performed with
pre-immune antibodies.
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Figure 7. Signal multiplexing by 14-3-3-binding phosphoprotein families in the vertebrates. (a) The diagram depicts how a 14-3-3 dimer is envisaged to bind to
REEP4 via phosphorylated Ser152, and also Ser224 that is phosphorylated in phorbol ester-stimulated cells. The N-terminal membrane-tethering hydrophobic hairpin
is also indicated. (b) 14-3-3-binding sites of the human REEP proteins. Serine and threonine residues reported to be phosphorylated in the literature (www.
phosphosite.org) and/or in this study are in lower case, and phosphorylated 14-3-3-binding residues are in bold: the lynchpin (phosphoSer152 in REEP4) is indicated
by the symbol and second 14-3-3-binding sites in grey (pSer192 in REEP1, pSer225 in REEP3, pSer224 of REEP4). (c) A signal multiplexing system: this represents
the scenario where a 2R-ohnologue family of 14-3-3-binding proteins (A to D) has evolved such that they each maintain a common lynchpin phosphorylation site for
binding to 14-3-3 and have a variable second site, which can be phosphorylated by different kinases. Such multiplexers have considerable potential for regulatory
variation: They could operate in multiple-input, multiple-output (MIMO) mode, or multiple-input, single-output (MISO) mode, generate graded output responses
that increase in intensity as each target protein in the family is engaged, or be all-or-nothing devices that trigger an output only when every family member has
been captured by a 14-3-3 dimer.
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change and be regulated by different kinases on different
family members [24,41]. Even minor sequence changes have
the potential to rewire the signalling inputs from protein
kinases. For example, PKB/Akt and SGK create phosphory-
lated RxRxx(pS/pT) motifs, whereas p90RSK prefers to
phosphorylate the serine within RxRxx(pS), and Lats kinases
phosphorylate HxRxx(pS/pT) sites [42,43]. The resulting
2R-ohnologue protein families would enable a given process
to be regulated by more signalling inputs than could be
accommodated by a single protein (figure 7c). Such signal
multiplexing is reminiscent of the powerful multiple-
input, multiple-output (MIMO) signalling arrays that boost
signal-to-noise ratios and communication flows in smart-
phone networks.
Human 14-3-3-binding 2R-ohnologues include com-
ponents of developmental and growth factor signalling
pathways such as insulin-receptor substrate proteins, fibro-
blast growth factor receptors, Raf kinases and other protein
kinase families [3], as well as many downstream target pro-
teins that link these signalling pathways to the regulation of
membrane trafficking, metabolism, the cell cycle and gene
expression [44,45] (figure 2). The concept of MIMO arrays
should therefore be a useful framework for understand-
ing complexities of growth factor signalling pathways,
including signal integration, feedback regulation, oncogeneaddiction and differential responses of different cell types.
These ideas provide impetus to explore how the extra
signal-streaming capacity of such MIMOs contributed to the
evolution of complex vertebrate forms.
A special feature of vertebrate embryo development
is that cells in the neural crest undergo an epithelial–
mesenchymal transition (EMT) and migrate to different
regions of the embryo, where they differentiate into a wide
variety of cell types that contribute to craniofacial structures,
heart valves, pigmented skin cells and many other vertebrate
features. A reactivation of the EMT programme is thought to
underlie the aggressive metastatic behaviours of cancers,
such as melanoma. It is therefore interesting that key tran-
scription factors that mediate the EMT and neural crest
cell differentiation belong to 14-3-3-binding 2R-ohnologue
families, including snail, MITF and TLX-2 [46–48].
We therefore suggest that neofunctionalization, in
terms of divergence of regulatory phosphorylations and
14-3-3-binding specificities, made a greater contribution to
2R-ohnologue survival than has been realized. However,
we do not reject paradigms of 2R-ohnologue retention
driven by dosage balance and subfunctionalization. Indeed,
the human 14-3-3s are themselves also 2R-ohnologues,
which suggest that 14-3-3s coevolved with their targets, in
line with the gene–dosage balance hypothesis. The concept
of gene–dosage was developed for smaller pathways and
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14-3-3-interactome will require the emergent properties of the
whole network to be defined. Efforts in this direction are
under way. For example, proteomics experiments are identify-
ing which proteins are phosphorylated and captured by
14-3-3s in response to different extracellular stimuli [44,45].
The singleton human 14-3-3 targets also went through the
WGD events before being returned to singleton status by gene-
loss mutations in all but one of the paralogues. For the species
to survive, 14-3-3 signalling had still to be viable throughout
these changes in gene–dosage, but perhaps these proteins
were more efficient as singletons. It may be significant that
several 14-3-3-binding singletons belong to ancient multi-
protein complexes: Rictor, raptor and PRAS40/AKTS1 are in
the nutrient-sensing mTOR (mammalian target of rapamycin)
complexes; BAD and B2L11 are central components of
the apoptotic machinery; and EDC3 (enhancer of mRNA-
decapping protein 3) is part of an mRNA-decapping complex
[44,45]. Also, 14-3-3-binding sites in two singletons are ancient,
one in the human transcriptional repressor capicu´a is con-
served in the Drosophila protein [49], and the mammalian
(PI4KIIIb) and Saccharomyces cerevisiae (PIk1) forms of the
Golgi regulator phosphatidylinositol 4-kinase also share a
common 14-3-3-binding site [14,50].
We note that plants, which have their own history of
whole-genome duplications, also have multiple 14-3-3s [51]
and 14-3-3-binding proteins belonging to multi-protein
families [52,53]. It would be interesting to discover whether
there are mechanistic parallels between the evolution of
vertebrate and plant 14-3-3-interactomes. Saccharomyces
cerevisiae has also been through a WGD [54], raising the
question of how this event influenced the evolution of its
two 14-3-3 proteins and their phosphoprotein targets.4.2. Case study of a disease-linked 14-3-3-binding
2R-ohnologue family: the REEP proteins
Here, 103 candidate lynchpins were identified, defined as 14-
3-3-binding sites that are conserved across members of a
human 2R-ohnologue family, and which align with Ser/Thr
residues in the single pro-orthologues in the basal invert-
ebrates of our chordate lineage (electronic supplementary
material, figure S4). However, while sequence alignments
are useful, only the type of biochemical analyses performed
here for the REEP proteins can define 14-3-3-binding
phosphosites with confidence.
Interestingly, 46 per cent (100/216) of experimentally
defined 14-3-3-binding phosphosites and 47 per cent
(49/103) of the potential 14-3-3-binding lynchpins have a
phosphorylatable serine in the –2 position (see electronic
supplementary material, figure S2 and table S2) [14,55],
including that in the REEP 1–4 family (figure 7b). The
REEP lynchpin (phosphoSer152 in REEP4) evolved in a
step-wise manner with the basic residues being in place
first, then a potential 14-3-3-binding site was formed before
the 2R-WGD event, thereby making phosphoSer152 a poten-
tial lynchpin. The –2 serine (phosphoSer150 in REEP4) is in
some, but not all, bilaterian invertebrate REEP proteins.
This feature will require further work to define the relevant
kinases and regulatory significance of the juxtaposed
phosphoSer residues.As well as acting as a lynchpin 14-3-3-binding site, the
Ser152 region of REEP4 is involved in interactions with the
RAB3GAP1–RAB3GAP2 heterodimer, which is a GTPase-
activating protein for Rab3 that mediates neurotransmitter
release. However, REEP4 cannot bind to 14-3-3 and to
RAB3GAP1–RAB3GAP2 at the same time. Mutation of
REEP1 causes hereditary spastic paraplegia 31 in humans,
which is characterized by progressive weakness and stiffness
of the legs, and mutation of REEP4 causes lower body paraly-
sis in an animal model [31,32,56]. Mutations in RAB3GAP1
and RAB3GAP2 cause the autosomal recessive Warburg
Micro and Martsolf syndromes, which involve congenital
cataracts, microphthalmia, postnatal microcephaly and devel-
opmental delay [38–40]. It is intriguing to find a molecular
connection between these two types of disorder. Regulated
membrane trafficking is a molecular theme. One hypothesis
is that REEP4 and related proteins are involved in trafficking
of synaptic vesicles towards the ends of axons, during which
events the REEP4 undergoes a phosphorylation-dependent
switch that determines whether it binds to 14-3-3s or engages
with RAB3GAP1–RAB3GAP2 to modulate Rab3-mediated
neurotransmitter release. The motor neurons that run from
the brainstem to connect with the lower motor neurons
would be vulnerable to long-distance trafficking problems
(consistent with the REEP mutations causing paraplegia),
whereas many neurons would be affected by neurotransmitter
release problems (consistent withWarburgMicro andMartsolf
syndromes). It is unclear how the motor function of REEP pro-
teins relates to the separate literature on how REEPs regulate
cell surface expression of odourant and taste receptors [34],
though mechanisms controlling sensory inputs and vertebrate
motion may be evolutionarily linked [57].
The KDM3B (JMJD1B), REEP2, EGR1 and CTNNA1 genes
lie within the MDS 5q31.2 CDR1 microdeletion region that
is linked to the aggressive form of MDS and acute myeloid
leukaemia [35,58–60], and this region also constitutes a
2R-WGD paralogon (figure 4). Within the conceptual frame-
work of MIMO systems, it is interesting that peripheral
neuropathy is a phenotype shared by hereditary spastic para-
plegia 31 (REEP1) and MDS with 5q31.2 deletion (REEP2).
These considerations suggest a case for examining whether
REEP2 contributes to the aetiology of MDS.
4.3. The MIMO imbalance disease hypothesis
The 2R-ohnologues were previously reported to be enriched
in disease genes [2–4]. Indeed, the 14-3-3s are themselves
linked to diseases: chromosome deletions including the
14-3-3 epsilon gene result in craniofacial dysmorphisms,
brainstem reduction in 14-3-3 protein levels has been ident-
ified in sudden infant death syndrome, and certain cancers
involve changes in expression of specific 14-3-3s. Also,
many 14-3-3-binding 2R-ohnologues are linked to disease,
including cancer (the protein kinase B-Raf, E3 ubiquitin
ligase mdm2, tumour suppressor p53/TP53 and transcription
factor MITF), metabolic disorders (AS160, TBC1D1), move-
ment disorders (ataxin-1, REEP1, protein kinase LRRK2)
and developmental RASopathies (disorders linked to the
Ras pathway; C-Raf and E3 ubiquitin ligase Cbl) [61–63].
It makes sense to suppose that if a critical regulatory
function were performed by a single protein in an animal
like amphioxus, then its mutation might be lethal. In contrast,
mutation or loss of one or other component of a delicately
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of the family can at least partially compensate for the function
(figure 7c). However, the loss of a regulatory input may make
the function become uncoordinated with other cellular
processes, thereby causing the debilitating disorder.
While it was previously stated that disease is generally
linked with just one member of any given 2R-ohnologue
family [4], the situation appears to be more complicated,
with mutations in different protein family members giving
rise to different diseases, as has been discussed here for the
REEP family. Another multi-disorder family is the Raf
kinases, comprising B-Raf, A-Raf and C-Raf/Raf-1. B-Raf is
mutated to an active V600E form in approximately 50 per
cent of melanomas, and drugs that inhibit B-Raf-V600E
have clinical efficacy [64]. However, when the patient also
has cells with activated Ras, the drug-inhibited B-Raf inter-
acts with other Raf proteins, facilitating their activation
via Ras, which may promote tumour growth [65,66].
The activation of C-Raf/Raf-1 by Ras can be inhibited by
14-3-3 binding to protein kinase A-phosphorylated sites on
C-Raf/Raf-1 [67]. Moreover, mutations that impair 14-3-3
binding to C-Raf, and hence promote its activation, cause
developmental RASopathies (including the pSer259 14-3-3-
binding phosphosite and Ser257, which we note is a
phosphorylatable –2 serine residue) [68,69].
The REEP and Raf examples illustrate how the increased
complexity of MIMO-based systems has gone hand-in-hand
with increased vulnerability to disease during embryogenesis
and adulthood, and emphasize that the study of ‘single gene’
diseases should take account of the potential interplay
between the disease protein and other members of its
2R-ohnologue family.
Finally, over the evolutionary time-scale, variations in the
signalling configurations of MIMO systems could also help
explain the variety of species of mammals, reptiles, birds,
amphibians and fish. For example, we were interested to
notice that REEP4 is missing from fish, while IRS3 (insulin
receptor substrate 3) is a pseudogene in humans, but is a
functional gene in mice. In other words, genetic disorders
and genetic variety are on the same continuum. It will be fas-
cinating to compare the patterns of 2R-ohnologue loss and
retention in different vertebrates, and try to relate these
patterns to the special features of each lineage.5. Material and methods
5.1. Gold and silver 14-3-3-binding proteins
The list of ‘gold standard’ mammalian proteins for which
14-3-3-binding sites were reported up to August 2010 [14,24]
was revised and updated to August 2011. A list of ‘silver
standards’ was also prepared from the literature, meaning pro-
teins demonstrated to display direct and phosphorylation-
dependent binding to 14-3-3s, but where phosphorylated
residues were not identified. Relevant references are cited in
electronic supplementary material, table S1.
5.2. Protein mapping
The datasets fromMakino &McLysaght [2] andHuminiecki &
Heldin [3] were used to define the ohnologue families. Both
papers used Ensembl identifiers. The Biomart tool at Ensembl(http://www.ensembl.org/biomart/martview/) was used to
create a table with Ensembl Gene ID (Ensembl Gene 65, Homo
sapiens genes GRCh37.p5) andUniProt IDs (UniProt/SwissProt
ID, UniProt/SwissProt Accession). The table was implemented
as a dictionary in a python script tomap the Ensembl identifiers
onto UniProt IDs. The dataset of Huminiecki & Heldin [3]
(see electronic supplementary material, table S1) clusters
ohnologue families using the TreeFam ID as identifier, and
no further steps were required. The ohnologue pairs from elec-
tronic supplementarymaterial, table S1, worksheet 7 ofMakino
& McLysaght [2] were clustered into families and the family
size computed with a python script. A progressive number
was used as family identifier. A second python script was
used to create a VisANT XML file to group each ‘node’ protein
of electronic supplementary material, table S3 into the
correspondent ohnologue family ‘group’.
5.3. Genetic association of diseases
The gold and silver standard proteins were assigned to the
relevant diseases based on data in electronic supplementary
material, tables S4a (for human) and S5a (for mouse) of
Zhang et al. [70] (also see [28]). The gene2accession table
from NCBI (ftp://ftp.ncbi.nlm.nih.gov/gene/DATA/) was
used to create a python dictionary to convert the gene
name to the Gene Identifiers and UniProt IDs. The BioMart
service at Ensembl was used to retrieve the human homol-
ogues of the mouse UniProt accession IDs (two proteins
were defined as homologues if they share 80% amino acid
identity). The OMIM diseases were retrieved using the
DAVID resource (http://david.abcc.ncifcrf.gov/). The disease
classes (manually assigned) are based on Zhang et al. [70].
5.4. Biochemical analyses
Biochemical analyses of REEP-GFP proteins used the
methods reported in Johnson et al. [24]. HEK293 cells cul-
tured in medium containing 10 per cent (v/v) foetal bovine
serum were transfected with plasmids to express REEP4-
GFP (wild-type) and REEP4-S152A-GFP, as indicated. After
24 h, cells were serum-starved for 8 h, then stimulated with
epidermal growth factor (EGF, 100 ng ml–1 for 15 min), phor-
bol-12-myristate-13-acetate (PMA, 100 ng ml21 for 30 min)
and adenylate cyclase activator forskolin (20 mM for
30 min), as indicated. Where shown, cells were incubated
with p90 ribosomal S6 kinase (p90RSK) inhibitor BI-D1870
(10 mM for 30 min), pan-PKC inhibitor (Go¨6983, 1 mM for
30 min), Go¨6976 (which inhibits PKCa and PKCb1, but not
PKCd, -1 or -z; 1 mM for 30 min) and non-specific protein
kinase A inhibitor H-89 (30 mM for 30 min) prior to stimu-
lation. REEP4-GFP was isolated from cell lysates (2.5 mg)
usingGFP-Trap agarose, and analysed. Antibodies that specifi-
cally recognize human REEP4 phosphorylated on Ser152 were
raised in sheep against the synthetic phosphopeptide
AGRLRSF(s)MQDLRC (residues 145–157, where lower case
‘s’ denotes phosphoSer152, plus Cys for coupling: ref. S500B,
second bleed used).6. Acknowledgements
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